back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-04 12:15 Tx date 2026-09-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$41,923
+5,144 vol $8.15 each |
31,373 | |
| Filed 2026-09-04 12:13 Tx date 2026-09-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-5,144 vol |
133,036 | |
| Filed 2026-06-05 14:42 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,593 vol |
1,593 | |
| Filed 2026-06-05 14:40 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,507 vol |
138,180 | |
| Filed 2026-06-05 14:36 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
59 - Exercise for cash
|
-1,416 vol |
0 | |
| Filed 2026-06-05 14:27 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,229 vol |
26,229 | |
| Filed 2026-06-05 14:25 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,229 vol |
1,416 | |
| Filed 2025-06-10 12:37 Tx date 2025-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+2,645 vol |
2,645 | |
| Filed 2025-06-10 12:35 Tx date 2016-09-27 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 12:34 Tx date 2025-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+17,012 vol |
127,673 | |
| Filed 2024-10-15 17:49 Tx date 2024-10-11 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,772
+22,727 vol $1.75 each |
128,640 | |
| Filed 2024-06-07 14:56 Tx date 2024-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$593,082
+15,542 vol $38.16 each |
110,661 | |
| Filed 2023-10-30 18:04 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,646
+15,800 vol $1.37 each |
110,900 | |
| Filed 2023-10-30 18:03 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$546.00
+400 vol $1.36 each |
95,100 | |
| Filed 2023-10-30 18:03 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,768
+13,800 vol $1.36 each |
94,700 | |
| Filed 2023-10-30 18:02 Tx date 2023-07-31 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-242,700 vol |
80,900 | |
| Filed 2023-10-30 10:05 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,646
+15,800 vol $1.37 each |
353,600 | |
| Filed 2023-10-30 10:04 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$546.00
+400 vol $1.36 each |
337,800 | |
| Filed 2023-10-30 10:04 Tx date 2023-10-27 |
$TH
Theratechnologies Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,768
+13,800 vol $1.36 each |
337,400 | |
| Filed 2023-08-24 16:45 Tx date 2023-08-24 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-967,500
-25,000 vol $38.70 each |
25,000 |